Shuai Yi

IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis.

Junjian Liu, Dongdong Wu, Zhihui Kuang, 2020, International immunopharmacology.

Effect of Traditional Chinese Medicine on the Cardiovascular Diseases

Shuai Yi, Qi Zhao, Zhixi Hu, 2022, Frontiers in Pharmacology.

A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy

Junjian Liu, Zhihui Kuang, Min Wu, 2020, Antibody therapeutics.